These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10779784)

  • 1. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts.
    Cerboni C; Mousavi-Jazi M; Linde A; Söderström K; Brytting M; Wahren B; Kärre K; Carbone E
    J Immunol; 2000 May; 164(9):4775-82. PubMed ID: 10779784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
    Fletcher JM; Prentice HG; Grundy JE
    J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell-mediated lysis of autologous HCMV-infected skin fibroblasts is highly variable among NK cell clones and polyclonal NK cell lines.
    Carr WH; Little AM; Mocarski E; Parham P
    Clin Immunol; 2002 Nov; 105(2):126-40. PubMed ID: 12482387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j.
    Cerboni C; Achour A; Wärnmark A; Mousavi-Jazi M; Sandalova T; Hsu ML; Cosman D; Kärre K; Carbone E
    Eur J Immunol; 2006 Mar; 36(3):732-41. PubMed ID: 16479538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors.
    Lang P; Griesinger A; Hamprecht K; Feuchtinger T; Schumm M; Neuhäuser F; Greil J; Martin D; Handgretinger R; Niethammer D
    Hum Immunol; 2004 May; 65(5):423-31. PubMed ID: 15172441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells.
    Djaoud Z; Riou R; Gavlovsky PJ; Mehlal S; Bressollette C; Gérard N; Gagne K; Charreau B; Retière C
    J Innate Immun; 2016; 8(4):374-85. PubMed ID: 27116381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity.
    Cerboni C; Mousavi-Jazi M; Wakiguchi H; Carbone E; Kärre K; Söderström K
    Eur J Immunol; 2001 Oct; 31(10):2926-35. PubMed ID: 11592068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18.
    Odeberg J; Cerboni C; Browne H; Kärre K; Möller E; Carbone E; Söderberg-Nauclér C
    Scand J Immunol; 2002 Feb; 55(2):149-61. PubMed ID: 11896931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte Immunoglobulin-Like Receptor 1-Expressing Human Natural Killer Cell Subsets Differentially Recognize Isolates of Human Cytomegalovirus through the Viral Major Histocompatibility Complex Class I Homolog UL18.
    Chen KC; Stanton RJ; Banat JJ; Wills MR
    J Virol; 2016 Jan; 90(6):3123-37. PubMed ID: 26739048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.
    Tomasec P; Braud VM; Rickards C; Powell MB; McSharry BP; Gadola S; Cerundolo V; Borysiewicz LK; McMichael AJ; Wilkinson GW
    Science; 2000 Feb; 287(5455):1031. PubMed ID: 10669413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of killer cell immunoglobulin-like receptors (KIRs) by natural killer cells during acute CMV infection after kidney transplantation.
    de Rham C; Hadaya K; Bandelier C; Ferrari-Lacraz S; Villard J
    Transpl Immunol; 2014 Sep; 31(3):157-64. PubMed ID: 25158213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.
    Mazzarino P; Pietra G; Vacca P; Falco M; Colau D; Coulie P; Moretta L; Mingari MC
    Eur J Immunol; 2005 Nov; 35(11):3240-7. PubMed ID: 16224817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins.
    Odeberg J; Browne H; Metkar S; Froelich CJ; Brandén L; Cosman D; Söderberg-Nauclér C
    J Virol; 2003 Apr; 77(8):4539-45. PubMed ID: 12663760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells.
    Prod'homme V; Griffin C; Aicheler RJ; Wang EC; McSharry BP; Rickards CR; Stanton RJ; Borysiewicz LK; López-Botet M; Wilkinson GW; Tomasec P
    J Immunol; 2007 Apr; 178(7):4473-81. PubMed ID: 17372005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis.
    Ulbrecht M; Martinozzi S; Grzeschik M; Hengel H; Ellwart JW; Pla M; Weiss EH
    J Immunol; 2000 May; 164(10):5019-22. PubMed ID: 10799855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced recognition of human NK receptors after influenza virus infection.
    Achdout H; Arnon TI; Markel G; Gonen-Gross T; Katz G; Lieberman N; Gazit R; Joseph A; Kedar E; Mandelboim O
    J Immunol; 2003 Jul; 171(2):915-23. PubMed ID: 12847262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes.
    Romagnani C; Pietra G; Falco M; Mazzarino P; Moretta L; Mingari MC
    Hum Immunol; 2004 May; 65(5):437-45. PubMed ID: 15172443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation.
    Falk CS; Mach M; Schendel DJ; Weiss EH; Hilgert I; Hahn G
    J Immunol; 2002 Sep; 169(6):3257-66. PubMed ID: 12218145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ.
    Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V
    Front Immunol; 2021; 12():532484. PubMed ID: 33897679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.